Site içinde arama yapın

Wang Judy bir ses eklendi Other
2026-05-28 08:09:27 -

New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine Project
The treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!
Wang Judy bir ses eklendi Other
2026-06-10 06:59:58 -

The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...

0 Yorumlar 0 hisse senetleri 1K Views 0 önizleme

Please log in to like, share and comment!